Cardiovascular diseases (CVDs) remain the world’s deadliest health threat, accounting for nearly 18 million deaths annually, according to the World Health Organization (WHO). This grim reality has spurred an unprecedented demand for effective cardiovascular drugs, propelling the global market to new heights. From statins that lower cholesterol to anticoagulants preventing blood clots and...